• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Medical Tubing and Extrusion

Medical tubing and extrusion technologies

  • Catheters
  • Components
    • Connectors
    • Needles and Injections
    • Seals
    • Tubing Components
  • Manufacturing
    • Coatings
    • Extrusions
    • Machining
    • Injection Molding
    • Insert molding
    • Tools
  • Materials
    • Advanced Materials
    • Silicone
  • Research & Development
  • Suppliers

Ablative Solutions raises $91.4M in Series D financing round

June 13, 2022 By Danielle Kirsh

Ablative Solutions today announced it completed the fourth tranche of its Series D financing round and raised $91.4 million.

Wakefield, Massachusetts-based Ablative Solutions earmarked the funds to complete the company’s ongoing Target BPI pivotal trial that is evaluating its alcohol-mediated renal denervation procedure.

“We are extremely pleased with the completion of our Series D financing round and the continued support of our investors, despite the challenges of the COVID-19 pandemic,” President and CEO Kate Rumrill said in a news release.

Ablative Solutions develops the Peregrine System Kit for renal denervation. It has two components – Peregrine System infusion catheter and dehydrated alcohol – that work together to reduce blood pressure in individuals with uncontrolled hypertension. The Peregrine System delivers small doses of dehydrated alcohol directly into the space outside of the renal artery to block the overactive signaling of sympathetic nerves.

“We continue to be appreciative of the amazing group of clinical partners we have and the progress made in our studies within our TARGET BP Program” said Rumrill. “We are encouraged by these efforts and look forward to sharing results when available.”

The Peregrine System Kit for renal denervation is not approved for commercial distribution and is limited to investigational use in clinical trials. The Peregrine System infusion catheter is FDA cleared for the infusion of diagnostic and therapeutic agents into the perivascular area of the peripheral vasculature and is CE marked for the infusion of a neurolytic agent to reduce systemic blood pressure.

Filed Under: Catheters Tagged With: Ablative Solutions

Primary Sidebar

DeviceTalks Tuesdays

DeviceTalks Tuesdays
MDO ad

Stay Current

Need Medical Tubing news in a minute?
We Deliver!

Medical Tubing + Extrusion newsletter get you caught up on all the mission critical news you need in medical tubing. Sign up today.

Enews Sign up

Sponsored Content

A new way to access scientific papers?

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website

Footer

Inv Logo

MASSDEVICE MEDICAL NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech 100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Souring
R&D World

Medical Tubing & Extrusion

Subscribe to our e-newsletter
Advertise with us
About
Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS